Clostridium difficile infection (CDI) is an intestinal infection usually acquired in hospital settings, after antibiotic treatment. The clinical spectrum of CDI ranges from mild diarrhoea to severe life-threatening pseudomembranous colitis. In the recent years, an increased incidence of CDI has been reported in Europe and worldwide.
In his speech to the Informal Health Council on 5th July, ECDC Director Marc Sprenger outlined the lessons learnt from the EHEC/STEC outbreak in EU, as well as the need to strengthen EU cooperation against epidemics.
This review summarises the clinical features, diagnosis and treatment of gnathostomiasis and highlights the rare but important different neurological syndromes that can occur as a consequence of migration of the worm within the CNS.
In recent years there have been a series of arguments and findings suggesting that Statins (HMG-CoA reductase inhibitors) which used widely to lower cholesterol levels may also be important in reducing the risk associated with severe infective conditions.